Yiqin Tong

Title: Yiqin Tong: Innovator in Nucleic Acid Technology

Introduction

Yiqin Tong is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of nucleic acid technology, particularly through his innovative patent. His work focuses on enhancing the efficiency of nucleic acid manipulation, which is crucial for various applications in biotechnology and medicine.

Latest Patents

Yiqin Tong holds a patent for a "Splint nucleic acid molecule for cyclizing single-stranded nucleic acid molecule and use thereof." This invention provides a splint nucleic acid molecule designed to cyclize a single-stranded nucleic acid molecule. The splint nucleic acid molecule consists of a 5' terminal fragment and a 3' terminal fragment. The 5' terminal fragment is tailored to form a first complementary region with the 5' terminal of the single-stranded nucleic acid molecule, while the 3' terminal fragment is suited to create a second complementary region with the 3' terminal of the same molecule. Notably, the lengths of the first and second complementary regions differ, which enhances the functionality of the nucleic acid molecule.

Career Highlights

Yiqin Tong is associated with BGI Genomics Co., Limited, a leading company in genomics and biotechnology. His role at BGI allows him to collaborate with other experts in the field and contribute to groundbreaking research and development projects.

Collaborations

One of his notable coworkers is Chong Tang, with whom he collaborates on various projects related to nucleic acid technology. Their combined expertise fosters innovation and advances the understanding of nucleic acid applications.

Conclusion

Yiqin Tong's contributions to nucleic acid technology through his patent and work at BGI Genomics Co., Limited highlight his role as a key innovator in the field. His research continues to pave the way for advancements in biotechnology and medicine.